» Articles » PMID: 1554030

Nicotine Withdrawal Symptoms and Psychiatric Disorders: Findings from an Epidemiologic Study of Young Adults

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 1992 Apr 1
PMID 1554030
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Earlier, the authors reported on the association of nicotine dependence with major depression and anxiety disorders in a group of young adults. This report describes the occurrence of withdrawal symptoms and their sociodemographic and psychiatric correlates in persons in that group who tried unsuccessfully to abstain from smoking.

Method: A random sample of 1,007 members of a health maintenance organization, 21-30 years old, were interviewed with a revised version of the NIMH Diagnostic Interview Schedule. Data on nicotine withdrawal came from a subset of 239 smokers who had tried unsuccessfully to quit or cut down on smoking.

Results: With two exceptions, each of the DSM-III-R nicotine withdrawal symptoms was reported by more than one-half of these smokers. Withdrawal symptoms were more severe in white than in black smokers but were unrelated to sex, educational level, or marital status. Persons with histories of major depression or any anxiety disorder reported more severe withdrawal symptoms than persons with neither of these disorders. Severity of withdrawal, or any specific symptom, did not account for the association between major depression and continued smoking. Furthermore, severity of withdrawal was unrelated to continued smoking.

Conclusions: While the long-term clinical significance of nicotine withdrawal is unclear, the evidence indicates that in the general population, abstinence from smoking is associated with a variety of disturbances, including a craving for cigarettes, dysphoria, and symptoms of irritability or nervousness. In this study disturbances were more severe in persons with histories of major depression or anxiety disorders.

Citing Articles

Do Antidepressants Worsen COPD Outcomes in Depressed Patients with COPD?.

Kaplan A Pulm Ther. 2024; 10(4):411-426.

PMID: 39516453 PMC: 11574234. DOI: 10.1007/s41030-024-00277-9.


Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial.

Caponnetto P, Campagna D, Ahluwalia J, Russell C, Maglia M, Riela P BMC Med. 2023; 21(1):220.

PMID: 37403047 PMC: 10321010. DOI: 10.1186/s12916-023-02919-2.


The experience of tobacco withdrawal symptoms among current smokers and ex-smokers in the general population: Findings from nationwide China Health Literacy Survey during 2018-19.

Cui Z, Li Y, Liu Z, Li L, Nie X, Zhou X Front Psychiatry. 2023; 13:1023756.

PMID: 36713929 PMC: 9880314. DOI: 10.3389/fpsyt.2022.1023756.


The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trial.

Foulds J, Veldheer S, Pachas G, Hrabovsky S, Hameed A, Allen S PLoS One. 2022; 17(11):e0275522.

PMID: 36322562 PMC: 9629593. DOI: 10.1371/journal.pone.0275522.


Impact of a soft tip nicotine-free harmless cigarette as part of a smoking cessation program with psychological support and varenicline: an integrated workplace smoking cessation intervention.

Maglia M, Caponnetto P, Polosa R, Russo C, Santisi G Health Psychol Res. 2021; 9(1):24506.

PMID: 34746480 PMC: 8567756. DOI: 10.52965/001c.24506.